E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression. (Q39597035)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21297666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21297666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21297666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

M-T Lau

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21297666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C Klausen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21297666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

7 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21297666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21297666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21297666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21297666%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

2753-2766

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21297666%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2011.6

21 January 2020

exact match

0 references

cites work

The biology of ovarian cancer: new opportunities for translation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

PTEN, more than the AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

A new mutational AKTivation in the PI3K pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

PTEN and the PI3-kinase pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Interaction of E-cadherin and PTEN regulates morphogenesis and growth arrest in human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Collective cell migration in morphogenesis, regeneration and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

E-Cadherin Suppresses Cellular Transformation by Inhibiting β-Catenin Signaling in an Adhesion-Independent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

MAGI-2 Inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

E-cadherin expression in primary carcinomas of the breast and its distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Restoring E-cadherin-mediated cell-cell adhesion increases PTEN protein level and stability in human breast carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

beta-catenin signaling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

The lipid phosphatase activity of PTEN is critical for its tumor supressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

The oncogenic activation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Expression of E-cadherin reduces bcl-2 expression and increases sensitivity to etoposide-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Regulation of PTEN transcription by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

TCF transcription factors, mediators of Wnt-signaling in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Protection against anoikis and down-regulation of cadherin expression by a regulatable beta-catenin protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

p120 catenin is essential for mesenchymal cadherin-mediated regulation of cell motility and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Molecular interactions in the submembrane plaque of cell-cell and cell-matrix adhesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6

Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.6